Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Russell H. Plumb | M | 65 |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 12 years |
| Gabriele Cerrone | M | 52 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 5 years |
| Briar Alpert | M | - |
University of Vermont
| 4 years |
| Michael Barrett | M | 81 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 10 years |
| Anna Novotney-Barry | F | - |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 2 years |
| Christopher McGuigan | M | 65 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 5 years |
| William D. Johnston | M | - |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA.
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 25 years |
| Jeffrey A. Barron | M | - |
University of Vermont
| 7 years |
| Amy M. Morris | F | - |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | - |
| Marc L. Preminger | M | 74 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 9 years |
| A. Keith Willard | M | 83 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 7 years |
| Fayez Hamzeh | M | - |
The Johns Hopkins University School of Medicine
| 3 years |
| Wendy Nunez | F | - |
University of Vermont
| 4 years |
| Laurie Brochu | F | - |
University of Vermont
| 3 years |
| Louise Moretto | F | - |
University of Vermont
| 4 years |
| Terrence A. Badger | M | - |
University of Vermont
| 4 years |
| Pete Allen | M | - |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 4 years |
| Robert W. Ker | M | - |
University of Vermont
| 4 years |
| James Kelly | M | 58 |
University of Vermont
| 4 years |
| Wendy M. Gross | F | - |
University of Vermont
| 4 years |
| David Charles Wishnow | M | - |
University of Vermont
| 4 years |
| Lex Crosett | M | - |
University of Vermont
| 3 years |
| Douglas Abrams | M | - |
University of Vermont
| 4 years |
| David Bradbury | M | - |
University of Vermont
| 4 years |
| John Niederhuber | M | 85 |
The Johns Hopkins University School of Medicine
| 4 years |
| Jon M. Christensen | M | - |
University of Vermont
| 4 years |
| William S. Friend | M | - |
University of Vermont
| 2 years |
| Jay Finnegan | M | - |
University of Vermont
| 5 years |
| Paul I. Rachlin | M | - |
University of Vermont
| 4 years |
| Douglas E. Motzenbecker | M | - |
University of Vermont
| 3 years |
| Chip Norton | M | - |
University of Vermont
| 4 years |
| Mindy Goldman | F | - |
University of Vermont
| 4 years |
| Scott Brun | M | 56 |
The Johns Hopkins University School of Medicine
| 4 years |
| Scott Nathaniel Brody | M | - |
University of Vermont
| 4 years |
| June Lee | M | 58 |
The Johns Hopkins University School of Medicine
| 4 years |
| Skiddy von Stade | M | - |
University of Vermont
| 4 years |
| Robert Avery | M | - |
The Johns Hopkins University School of Medicine
| 5 years |
| Alex Stimpson | M | - |
University of Vermont
| 4 years |
| Louise Moretto | F | - |
University of Vermont
| 4 years |
| Karen B. Chapman | M | - |
The Johns Hopkins University School of Medicine
| 3 years |
| Tom Leavitt | M | - |
University of Vermont
| 4 years |
| Nancy Patzwahl | F | 58 |
University of Vermont
| - |
| Lynn Waples | F | - |
University of Vermont
| 4 years |
| Raymond Pratt | M | 73 |
The Johns Hopkins University School of Medicine
| 4 years |
| Carlos Enrique Cavelier Lozano | M | - |
University of Vermont
| 4 years |
| Scott Thomas Myers | M | 59 |
University of Vermont
| 4 years |
| Kevin R. Milkey | M | - |
University of Vermont
| 4 years |
| Albert L. Stone | M | 64 |
University of Vermont
| 4 years |
| Peter Newman | M | - |
University of Vermont
| 4 years |
| John Miller | M | - |
University of Vermont
| 4 years |
| David Blittersdorf | M | - |
University of Vermont
| 4 years |
| Roland Morris | M | - |
University of Vermont
| 4 years |
| Anne H. Straton | F | 60 |
University of Vermont
| 4 years |
| Jordan S. Kassalow | M | - |
University of Vermont
| 4 years |
| Patrick Gallagher | M | 59 |
University of Vermont
| 4 years |
| Mark Barnhart Baribeau | M | - |
University of Vermont
| 4 years |
| Betsy G. Pecor | F | 58 |
University of Vermont
| 4 years |
| Stacey Brenner | F | - |
University of Vermont
| 4 years |
| John Michael Babyak | M | - |
University of Vermont
| 4 years |
| Liam Francis Dalton | M | - |
University of Vermont
| 4 years |
| Russ W. Burgess | M | - |
University of Vermont
| 4 years |
| Kurt Hall | M | 64 |
University of Vermont
| 4 years |
| Bart Alexander Johnston | M | - |
University of Vermont
| 4 years |
| Michael Weiser | M | 61 |
University of Vermont
| 4 years |
| Andrew Levine | M | 65 |
University of Vermont
| 4 years |
| Seth V. Hetherington | M | 71 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 4 years |
| Richard J. Koretz | M | 60 |
University of Vermont
| 4 years |
| John Francis McGarry | M | 66 |
University of Vermont
| 4 years |
| Marian Acker | F | 61 |
University of Vermont
| 4 years |
| Geoffrey Richard Hesslink | M | 59 |
University of Vermont
| 4 years |
| Gregory Hill Noble | M | - |
University of Vermont
| 4 years |
| John van Scoter | M | 62 |
University of Vermont
| 4 years |
| Mary Gallagher | F | 58 |
University of Vermont
| 4 years |
| Mary Gray | M | 71 |
University of Vermont
| 5 years |
| Charlene Begley | F | 57 |
University of Vermont
| 4 years |
| Rob Just | M | - |
University of Vermont
| 4 years |
| Bailey Bishop | M | - |
University of Vermont
| 4 years |
| Thomas M. Lescalleet | M | 61 |
University of Vermont
| 4 years |
| Diane W. Goodwin | F | - |
University of Vermont
| 4 years |
| Gerard S. DiFiore | M | - |
University of Vermont
| 4 years |
| Roger Crandall | M | - |
University of Vermont
| 4 years |
| Thomas P. H. Witschi | M | - |
University of Vermont
| 4 years |
| Jim Merriam | M | - |
University of Vermont
| 4 years |
| Tom Bergeron | M | - |
University of Vermont
| 4 years |
| Art Hogan | M | - |
University of Vermont
| 4 years |
| John Didsbury | M | 68 |
University of Vermont
| 3 years |
| Bradley Berggren | M | 58 |
University of Vermont
| 4 years |
| Adam P. Scholl | M | - |
University of Vermont
| 4 years |
| Ken Perkins | M | - |
University of Vermont
| 4 years |
| Thomas C. Letteri | M | - |
University of Vermont
| 5 years |
| Mark Gelfand | M | - |
The Johns Hopkins University School of Medicine
| 5 years |
| Peter E. Fleming | M | 66 |
University of Vermont
| 4 years |
| Michele L. Thompson | F | - |
University of Vermont
| 4 years |
| Peter van Raalte | M | 66 |
University of Vermont
| 4 years |
| Dave Haviland | M | - |
University of Vermont
| 4 years |
| David Pann | M | - |
University of Vermont
| 4 years |
| Mark Verdi | M | 57 |
University of Vermont
| 4 years |
| Corey L. Sclar | M | - |
University of Vermont
| 4 years |
| Damon Poole | M | - |
University of Vermont
| 4 years |
| Michelle Fallon | F | - |
University of Vermont
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John H. Vernachio
- Personal Network
